Market Cap: $579.99M
II
Ironwood Pharmaceuticals, Inc.
IRWD
NASDAQ (NASDAQ Global Select)USD
Market Cap: $579.99M
Ironwood Pharmaceuticals Drives Innovation in Gastrointestinal Therapeutics In a pivotal step forward in gastrointestinal medicine, Ironwood Pharmaceuticals announces significant advancements in its p…
Ironwood Pharmaceuticals Focuses on Advancements in Gastrointestinal Treatments Ironwood Pharmaceuticals stands at a pivotal moment as it prepares to release its quarterly earnings report on February…
Ironwood Pharmaceuticals: Advancing Gastrointestinal Care Through Innovation Ironwood Pharmaceuticals prepares to unveil its quarterly earnings report on February 25, 2026. As the company approaches t…
Ironwood Pharmaceuticals Boosts Focus on Gastrointestinal Therapies Amid Trading Surge Ironwood Pharmaceuticals Inc. is currently experiencing a remarkable surge in investor interest, as evidenced by…
Ironwood Pharmaceuticals' Expanding Role in Gastrointestinal Treatments Ironwood Pharmaceuticals, a key player in the gastrointestinal (GI) medicine sector, continues to make strides in addressing unm…
Ironwood Pharmaceuticals: Advancing Innovation Amidst Market Optimism Ironwood Pharmaceuticals stands at a pivotal moment as it continues to focus on developing innovative therapies for gastrointestin…
Ironwood Pharmaceuticals Strengthens its Position in Gastrointestinal Disorders Ironwood Pharmaceuticals remains focused on advancing its position in the gastrointestinal (GI) disorder market. The com…
I apologize, but it seems that you have not provided the content that you would like summarized. Please provide the relevant text, and I'll assist you in creating a summary as per your instructions.
Ironwood Pharmaceuticals Enhances Gastrointestinal Treatment Portfolio Ironwood Pharmaceuticals continues to advance its focus on gastrointestinal (GI) care with the recent launch of a new treatment a…
Ironwood Pharmaceuticals Shifts Focus to Apraglutide Development Amid Workforce Reductions Ironwood Pharmaceuticals, a biotechnology company renowned for its commitment to developing therapies for gas…
Ironwood Pharmaceuticals Prioritizes Apraglutide Development Amid Strategic Shift Ironwood Pharmaceuticals, Inc. announces a pivotal strategic shift, channeling its resources and efforts toward the ad…
Ironwood Pharmaceuticals Advances Gastrointestinal Care with Strategic Engagement Ironwood Pharmaceuticals, Inc. continues to solidify its position as a leader in gastrointestinal (GI) healthcare with…
Ironwood Pharmaceuticals Advances GI Healthcare Through Innovation and Engagement Ironwood Pharmaceuticals, Inc., a key player in the gastrointestinal (GI) healthcare sector, focuses on redefining sta…
Ironwood Pharmaceuticals: Resilience Amidst Financial Challenges Ironwood Pharmaceuticals, Inc. continues to demonstrate resilience in the gastrointestinal healthcare sector, as evidenced by its recen…